Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsHitting the target just got easier. For cataract patients with a history of refractive surgery, the Light Adjustable Lens (LAL) achieves refractive goals in about 94% of cases — far outpacing conventional IOLs. Presented at the AAO meeting, the findings highlight LAL's unique ability to fine-tune vision by up to 2 diopters post-surgery, making it the top choice for this challenging patient population.
Hitting the target just got easier for post-refractive cataract patients
Cataract surgery in patients with a history of corneal refractive surgery (like LASIK or PRK) is notoriously tricky. Modified corneal contours throw off IOL calculations, and even the best formulas leave a significant portion of patients missing their refractive target. At the American Academy of Ophthalmology meeting in New Orleans, Dr. Neda Shamie made the case that the Light Adjustable Lens (LAL, RxSight) is the best tool for this challenging group.
The LAL's key advantage: it can be fine-tuned after implantation using UV light, allowing adjustments of up to 2 diopters in either direction. That means even if the initial IOL calculation misses the mark, surgeons can still dial in the patient's vision post-op — without additional refractive surgery.
By the Numbers:
Why it matters: Post-refractive cataract patients come in with high expectations — and historically, surgeons have struggled to meet them. The LAL offers a reliable safety net, giving both patients and surgeons a meaningful second chance to optimize outcomes without resorting to additional procedures.
